T. Rowe Price Investment Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Sell |
322,406
-2,596,623
| -89% | -$138M | 0.01% | 518 |
|
|
2025
Q1 | $126M | Sell |
2,919,029
-1,350,794
| -32% | -$58.5M | 0.08% | 234 |
|
|
2024
Q4 | $240M | Buy |
4,269,823
+876,985
| +26% | +$49.3M | 0.15% | 154 |
|
|
2024
Q3 | $231M | Buy |
3,392,838
+451,636
| +15% | +$30.8M | 0.14% | 166 |
|
|
2024
Q2 | $124M | Buy |
2,941,202
+2,700
| +0.1% | +$114K | 0.08% | 244 |
|
|
2024
Q1 | $203M | Sell |
2,938,502
-12,800
| -0.4% | -$884K | 0.12% | 186 |
|
|
2023
Q4 | $218M | Sell |
2,951,302
-1,300
| -0% | -$96.2K | 0.14% | 172 |
|
|
2023
Q3 | $201M | Sell |
2,952,602
-8,244
| -0.3% | -$562K | 0.14% | 176 |
|
|
2023
Q2 | $278M | Buy |
2,960,846
+23,272
| +0.8% | +$2.19M | 0.19% | 132 |
|
|
2023
Q1 | $199M | Buy |
2,937,574
+2,283
| +0.1% | +$155K | 0.14% | 161 |
|
|
2022
Q4 | $145M | Sell |
2,935,291
-2,593
| -0.1% | -$128K | 0.11% | 194 |
|
|
2022
Q3 | $95.5M | Buy |
+2,937,884
| New | +$95.5M | 0.08% | 249 |
|